Shuttle Pharmaceuticals Holdings (SHPH) Accounts Payables (2021 - 2026)

Shuttle Pharmaceuticals Holdings' Accounts Payables history runs 6 years deep, the most recent figure standing at $1.8 million for Q1 2026.

• On a quarterly basis, Accounts Payables rose 99.55% year-over-year to $1.8 million in Q1 2026; TTM through Mar 2026 was $1.8 million, a 99.55% increase from a year earlier, with the FY2025 full-year figure at $1.5 million, up 143.68% from the prior year.
• Accounts Payables climbed to $1.8 million in Q1 2026 per SHPH's latest filing, from $1.5 million in the prior quarter.
• Across five years, Accounts Payables topped out at $1.8 million in Q1 2026 and bottomed at $446.0 in Q4 2023.
• The 5-year median for Accounts Payables is $447474.0 (2023), against an average of $685430.1.
• Across the five-year window, Accounts Payables tumbled 98.49% in 2022 and jumped 133666.82% in 2024, its largest moves.
• Year by year, Accounts Payables stood at $12500.0 in 2022, then tumbled by 96.43% to $446.0 in 2023, then soared by 133666.82% to $596600.0 in 2024, then surged by 143.68% to $1.5 million in 2025, then advanced by 23.11% to $1.8 million in 2026.
• Per Business Quant, the three latest SHPH Accounts Payables figures stand at $1.8 million (Q1 2026), $1.5 million (Q4 2025), and $1.5 million (Q3 2025).